DK1448567T3 - Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol - Google Patents

Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol

Info

Publication number
DK1448567T3
DK1448567T3 DK02797968.1T DK02797968T DK1448567T3 DK 1448567 T3 DK1448567 T3 DK 1448567T3 DK 02797968 T DK02797968 T DK 02797968T DK 1448567 T3 DK1448567 T3 DK 1448567T3
Authority
DK
Denmark
Prior art keywords
hexahydrofuro
furan
preparing
preparing hexahydrofuro
Prior art date
Application number
DK02797968.1T
Other languages
English (en)
Inventor
Bart Rudolf Romanie Kesteleyn
Dominique Louis Nestor Ghislain Surleraux
Peter J L M Quaedflieg
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1448567(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1448567T3 publication Critical patent/DK1448567T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02797968.1T 2001-09-10 2002-09-06 Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol DK1448567T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203416 2001-09-10
PCT/EP2002/010062 WO2003022853A1 (en) 2001-09-10 2002-09-06 Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol

Publications (1)

Publication Number Publication Date
DK1448567T3 true DK1448567T3 (da) 2010-04-26

Family

ID=8180908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02797968.1T DK1448567T3 (da) 2001-09-10 2002-09-06 Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol

Country Status (28)

Country Link
US (1) US7126015B2 (da)
EP (1) EP1448567B1 (da)
JP (1) JP4521185B2 (da)
KR (1) KR100894673B1 (da)
CN (2) CN101172980B (da)
AP (1) AP1758A (da)
AR (1) AR036501A1 (da)
AT (1) ATE453648T1 (da)
AU (1) AU2002333809C1 (da)
BR (1) BRPI0212341B8 (da)
CA (1) CA2459168C (da)
CY (1) CY1109974T1 (da)
DE (1) DE60234952D1 (da)
DK (1) DK1448567T3 (da)
EA (1) EA010883B1 (da)
ES (1) ES2338538T3 (da)
HK (1) HK1068887A1 (da)
HR (1) HRP20040320B1 (da)
HU (1) HU229505B1 (da)
IL (2) IL160166A0 (da)
MX (1) MXPA04002247A (da)
NO (1) NO328934B1 (da)
NZ (1) NZ531641A (da)
PL (1) PL224030B1 (da)
PT (1) PT1448567E (da)
SI (1) SI21463B (da)
WO (1) WO2003022853A1 (da)
ZA (1) ZA200401501B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261507A1 (en) * 2002-06-27 2005-11-24 Doan Brian D Preparation of stereoisomers of (3alpha/beta, 6alpha/beta)hexahydrofuro[2,3-b]furan-3-ol
WO2004060895A1 (ja) * 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
US7772411B2 (en) 2003-12-23 2010-08-10 Tibotec Pharmaceuticals Ltd. Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
TWI383975B (zh) * 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法
JP5549898B2 (ja) * 2006-03-31 2014-07-16 独立行政法人産業技術総合研究所 5−ヒドロキシメチル−2−フルフラールの製造法
SI2089371T1 (sl) 2006-11-09 2011-05-31 Tibotec Pharm Ltd Postopki za pripravo heksahidrofuro(2,3-b)furan-3-ola
CN101024646B (zh) * 2007-02-06 2010-07-14 启东东岳药业有限公司 4-甲氧基呋喃并呋喃-2-酮的纯化方法
AU2008244306A1 (en) 2007-04-27 2008-11-06 Tibotec Pharmaceuticals Ltd. Methods for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備(3r,3as,6ar)-六氫呋喃并〔2,3-b〕呋喃-3-基(1s,2r)-3-〔〔(4-胺基苯基)磺醯基〕(異丁基)胺基〕-1-苯甲基-2-羥基丙基胺基甲酸酯之方法
WO2010047819A1 (en) * 2008-10-24 2010-04-29 Concert Pharmaceuticals, Inc. Hydroxyethylamino sulfonamide derivatives
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
US9062065B2 (en) 2009-10-30 2015-06-23 Lupin Limited Process for preparation of darunavir and darunavir ethanolate of fine particle size
ES2516916T3 (es) 2010-01-28 2014-10-31 Mapi Pharma Limited Procedimiento para la preparación de darunavir e intermedios de darunavir
DK2643326T3 (da) 2010-11-23 2017-01-09 Mylan Laboratories Ltd Fremgangsmåde til fremstilling af (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol
US8802724B2 (en) 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
EP3795572B1 (en) 2012-07-24 2023-11-15 Laurus Labs Limited Darunavir propionate solvate
JPWO2014024898A1 (ja) * 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103864813B (zh) * 2012-12-18 2017-02-22 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
WO2016207907A1 (en) * 2015-06-25 2016-12-29 Msn Laboratories Private Limited Process for the preparation of [(1 s,2r)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1 -(phenylmethyl)propyl]-carbamic acid (3r,3as,6ar)hexahydro furo[2,3-b]furan-3-yl ester and its amorphous form
WO2017041228A1 (zh) * 2015-09-08 2017-03-16 浙江九洲药业股份有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN107043385B (zh) * 2016-02-05 2019-07-09 成都博腾药业有限公司 一种制备地瑞那韦中间体的方法
ES2881949T3 (es) 2016-10-27 2021-11-30 Gilead Sciences Inc Forma cristalina de base libre de darunavir
CN106928248B (zh) * 2017-02-04 2019-01-04 青岛科技大学 一种制备(3R,3aS,6aR)六氢呋喃并[2,3-b]呋喃-3-醇的方法
CN110272398B (zh) 2018-03-16 2022-11-29 江苏瑞科医药科技有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN114853774A (zh) * 2022-06-24 2022-08-05 盐城迪赛诺制药有限公司 一种达卢那韦关键中间体的制备方法
CN115557964A (zh) * 2022-10-18 2023-01-03 启东东岳药业有限公司 一种药物化合物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4325970A (en) * 1980-10-09 1982-04-20 Hoffmann-La Roche Inc. 15-Acetyl-prostaglandins
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
DE69415326T2 (de) 1993-08-24 1999-06-02 G.D. Searle & Co., Chicago, Ill. Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
RU2089545C1 (ru) * 1994-09-28 1997-09-10 Ярославский государственный технический университет Способ получения 2-метил-2-этил-1,3-диоксолан-4-ил-метилметакрилата
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
ES2229473T3 (es) * 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
WO1999067417A2 (en) 1998-06-23 1999-12-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Fitness assay and associated methods
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.

Also Published As

Publication number Publication date
CN101172980A (zh) 2008-05-07
HUP0402140A3 (en) 2007-05-29
HUP0402140A2 (hu) 2005-02-28
EA010883B1 (ru) 2008-12-30
CN101172980B (zh) 2011-11-16
HK1068887A1 (en) 2005-05-06
ES2338538T3 (es) 2010-05-10
HRP20040320B1 (hr) 2012-11-30
NZ531641A (en) 2005-08-26
DE60234952D1 (de) 2010-02-11
CA2459168A1 (en) 2003-03-20
BRPI0212341B8 (pt) 2021-05-25
NO20041434L (no) 2004-06-10
AP2004002981A0 (en) 2004-03-31
PT1448567E (pt) 2010-03-12
JP2005502707A (ja) 2005-01-27
MXPA04002247A (es) 2005-09-07
IL160166A0 (en) 2004-07-25
CN1553915A (zh) 2004-12-08
WO2003022853A1 (en) 2003-03-20
AU2002333809B8 (en) 2008-07-03
EA200400430A1 (ru) 2004-08-26
BR0212341A (pt) 2004-07-27
AU2002333809C1 (en) 2009-02-05
KR100894673B1 (ko) 2009-04-24
EP1448567B1 (en) 2009-12-30
AP1758A (en) 2007-07-30
PL367817A1 (en) 2005-03-07
CA2459168C (en) 2014-01-28
AU2002333809B9 (en) 2008-06-26
HU229505B1 (hu) 2014-01-28
EP1448567A1 (en) 2004-08-25
IL160166A (en) 2012-05-31
AU2002333809B2 (en) 2008-02-28
ATE453648T1 (de) 2010-01-15
NO328934B1 (no) 2010-06-21
HRP20040320A2 (en) 2005-04-30
CN100519561C (zh) 2009-07-29
PL224030B1 (pl) 2016-11-30
US7126015B2 (en) 2006-10-24
SI21463A (sl) 2004-10-31
CY1109974T1 (el) 2014-09-10
JP4521185B2 (ja) 2010-08-11
US20040249175A1 (en) 2004-12-09
AR036501A1 (es) 2004-09-15
SI21463B (sl) 2011-08-31
ZA200401501B (en) 2005-07-27
BRPI0212341B1 (pt) 2019-04-02
KR20040029425A (ko) 2004-04-06

Similar Documents

Publication Publication Date Title
DK1448567T3 (da) Fremgangsmåde til fremstilling af hexahydrofuro 2,3-B furan-3-ol
DK1161426T3 (da) Fremgangsmåde til fremstilling af furfural
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DE60135854D1 (de) 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-one
ATE314370T1 (de) 2-(pyridin-2-ylamino)-pyrido(2,3-d)pyrimidin-7- one
DE60207241D1 (de) 5-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidin-derivate
NO20034969D0 (no) Fremgangsmåte for fremstilling av olefiner
SI1416935T1 (sl) 4-amino-6-fenil-pirolo(2,3-d)pirimidinski derivati
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
AP2006003748A0 (en) Methods for the preparation of (3R,3aS,6aR) hexahydro-furo !2,3-b!furan-3-ol
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
DK1608653T3 (da) Substituerede 8-perfluoroalkyl-6,7,8,9- tetrahydropyrimido (1,2-a) pyrimidin-4-on derivater
DK1373268T3 (da) Fremgangsmåde til fremstilling af anagrelid
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
DE60205256D1 (de) Längliche, verfestigte thermoplastische hohlkörper
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1322651T3 (da) Bicykliske, heteroaromatiske forbindelser
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1417207T3 (da) Fremgangsmåde til fremstilling af 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-oner
ITBO20020602A1 (it) Apparecchiatura per la realizzazione di decori artistici,